Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5115334 | 0.93 | ALDH1A1 (0.45) | SMN1; SMN2ALDH1A1HPGDTHRBMAPT | |
| Hydrochloric Acid SCHEMBL5116601 | 0.92 | HPGD (0.44) | SMN1; SMN2ALDH1A1HPGDTHRBMAPT | |
| SCHEMBL12825219 | 0.85 | TACR1 (0.43) | SMN1; SMN2EPHX2TACR1 | |
| Ammonia Solution, Strong SCHEMBL5113991 | 0.85 | TACR1 (0.43) | SMN1; SMN2EPHX2TACR1 | |
| Hydrochloric Acid SCHEMBL5120599 | 0.85 | TACR1 (0.43) | SMN1; SMN2EPHX2TACR1 | |
| SCHEMBL2404585 | 0.84 | ATM (0.45) | SMN1; SMN2ALDH1A1HPGDGAAKMT2A | |
| Trifluoroacetic Acid SCHEMBL1457747 | 0.83 | SMN1; SMN2 (0.38) | SMN1; SMN2ALDH1A1HPGDTHRBMAPT | |
| Hydrochloric Acid SCHEMBL2401223 | 0.83 | ATM (0.44) | SMN1; SMN2ALDH1A1HPGDGAAKMT2A | |
| SCHEMBL12825008 | 0.81 | EPHX2 (0.47) | KMT2AMEN1EPHX2LMNACYP1A2 | |
| Hydrochloric Acid SCHEMBL5119487 | 0.81 | EPHX2 (0.46) | KMT2AMEN1EPHX2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080214807-A1 | Substituted Spiro Compounds and their Use for Producing Drugs | GRUENENTHAL GMBH (DE) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214807-A1 | Substituted Spiro Compounds and their Use for Producing Drugs | REN, PKD1, NR3C2 | SMN1; SMN2 4677/4885ALDH1A1 281/4885HPGD 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.